期刊文献+

X连锁多内分泌腺病肠病伴免疫失调综合征及其调节性T细胞异常的研究进展

IPEX and the abnormalities of regulatory T cells
原文传递
导出
摘要 X连锁多内分泌腺病肠病伴免疫失调综合征(IPEX)是一种罕见的原发性免疫缺陷病,以多器官自身免疫为特点,由FOXP3基因突变引起。该基因突变可致调节性T细胞发育、分化障碍和功能异常。调节性T细胞是具有免疫抑制功能的T细胞亚群,参与维持自身免疫稳态,其发育或功能异常可导致机体免疫稳态被打破而发生自身免疫。本文对IPEX临床特点、治疗和调节性T细胞的功能研究进展及与IPEX的关系进行阐述。 Immune dysregulation,polyendocrinopathy,enteropathy,X-linked syndrome(IPEX)is a rare primary immunodeficiency disease characterized by multiple organ autoimmunity,such as autoimmune enteropathy and T1 DM.It is confirmed that IPEX is caused by mutations in the forkhead box protein 3(FOXP3)gene.FOXP3 is critical for the development and function of regulatory T cells.Regulatory T cells is an immunoregulatory T cell subset involved in the maintenance of immune homeostasis.Regulatory T cells developmental deficiency or dyfunction is a hallmark of IPEX.In this review,the clinical characteristics and therapy of IPEX were described,and the impact of heritable mutations on the function of regulatory T cells was highlighted.
作者 蒋瑞妹 张梅
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第6期567-569,共3页 Chinese Journal of Diabetes
基金 国家自然科学基金(81070622 81370939) 江苏省六大人才高峰资助项目(2010-022)
关键词 调节性T细胞 X连锁多内分泌腺病肠病伴免疫失调综合征 FOXP3基因 Regulatory T cells Immune dysregulation,polyendocrinopathy,enteropathy,X-linked syndrome(IPEX) Forkhead box protein 3(FOXP3)gene
  • 相关文献

参考文献20

  • 1Bennett CL,Christie J,Ramsdell F, et al. The immune dysregu lation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet, 2001,27: 20-21.
  • 2Bindl L,Torgerson T,Perroni L,et al. Successful use of the new immune-suppressor sirolimus in IPEX(immune dysregulation, polyendoerinopathy, enteropathy, X-linked syndrome). J Pedi- atr, 2005,147 : 256-259.
  • 3Halabi-Tawil M, Ruemmele FM, Fraitag S, et al. Cutaneous mani- festations of immune dysregulation, polyendocrinopathy, enteropa- thy, X-linked (IPEX) syndrome. Br J Dermatol, 2009, 160: 645-651.
  • 4Nieves DS, Phipps RP, Pollock SJ, et al. Derma tologic and im- munologic findings in the immune dysregulation, polyendocri- nopathy, enteropathy, X-linked syndrome. Arch Dermatol, 2004,140 : 466-472.
  • 5Yong PL, Russo P,Sullivan KE. Use of sirolimus in IPEX and IPEX-like children. J Clin Immunol, 2008,28 : 581-587.
  • 6L6pez SI, Ciocca M, Oleastro M, et al. Autoimmune hepatitis type 2 in a child with IPEX syndrome. J Pediatr Gastroenterol Nutr, 2011,53 : 690-693.
  • 7Tsuda M, Torgerson TR, Selmi C, et al. The spectrum of au-toantibodies in IPEX syndrome is broad and includes anti-mito- chondrial autoantibodies. J Autoimmun, 2010,35 : 265-268.
  • 8Huter EN, Natarajan K, Torgerson TR, et al. Autoantibodies in scurfy mice and IPEX patients recognize keratin. J Invest Der- matol, 2010,130 : 1391-1399.
  • 9Gambineri E, Perroni L, Passerini L, et al. Clinical and molecu- lar profile of a new series of patients with immune dysregula- tion, polyendoerinopathy, enteropathy, X-linked syndrome: in- consistent correlation between forkhead box protein 3 expres- sion and disease severity. J Allergy Clin Immunol, 2008, 122: 1105-II12.
  • 10H ennezel E, Ben-Shoshan M, Oehs HD, et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syn- drome. N Engl J Med, 2009,361:1710-1713.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部